Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

immunohistochemistry

  • You have access
    High Receptor-interacting Serine/Threonine-protein Kinase 3 (RIP3) Expression Serves as an Independent Poor Prognostic Factor for Triple-negative Breast Carcinoma
    YUMIN CHUNG, SINAE KIM, HYUN-SOO KIM and SUNG-IM DO
    Anticancer Research May 2022, 42 (5) 2753-2761; DOI: https://doi.org/10.21873/anticanres.15754
  • You have access
    Chloride Intracellular Channel 1 Expression Is Associated With Poor Prognosis of Lung Adenocarcinoma
    YUICHIRO YASUDA, TATSUYA NAGANO, NAOE JIMBO, TATSUNORI KIRIU, RATOE SURAYA, DAISUKE HAZAMA, MASATSUGU YAMAMOTO, YOSHIMASA MANIWA, YOSHIHIRO NISHIMURA and KAZUYUKI KOBAYASHI
    Anticancer Research January 2022, 42 (1) 271-277; DOI: https://doi.org/10.21873/anticanres.15482
  • You have access
    Clinical Significance of Serglycin Expression in Human Breast Cancer Patients
    KEIKO HOSOYA, KANAE NOSAKA, TOMOHIKO SAKABE, MAKOTO WAKAHARA, YUKI OSHIMA, YOSHIMASA SUZUKI, HIROSHIGE NAKAMURA and YOSHIHISA UMEKITA
    Anticancer Research January 2022, 42 (1) 279-285; DOI: https://doi.org/10.21873/anticanres.15483
  • You have access
    Prognostic Value of Copine 1 in Patients With Renal Cell Carcinoma
    IMAN M. TALAAT, EMAN ABU-GHARBIEH, AMAL HUSSEIN, MAHMOOD HACHIM, ISRAA SOBHY, MOHAMED ELADL and WASEEM EL-HUNEIDI
    Anticancer Research January 2022, 42 (1) 355-362; DOI: https://doi.org/10.21873/anticanres.15493
  • You have access
    SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
    PIOTR CIERPIKOWSKI, ANNA LIS-NAWARA and JULIA BAR
    Anticancer Research November 2021, 41 (11) 5405-5413; DOI: https://doi.org/10.21873/anticanres.15352
  • You have access
    Ovarian Serous Carcinoma With a Novel HSP90AB1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma
    JINPING LAI, CAILI TONG and JEREMY R. CHIEN
    Anticancer Research September 2021, 41 (9) 4417-4422; DOI: https://doi.org/10.21873/anticanres.15248
  • You have access
    Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma
    MAKOTO KAWASAKI, TOMOHIKO SAKABE, ISAMU KODANI and YOSHIHISA UMEKITA
    Anticancer Research September 2021, 41 (9) 4563-4570; DOI: https://doi.org/10.21873/anticanres.15269
  • You have access
    PD-L1 Expression and Clinicopathological Factors in Renal Cell Carcinoma: A Comparison of Antibody Clone 73-10 With Clone 28-8
    JUNICHI IKEDA, CHISATO OHE, TAKASHI YOSHIDA, HARUYUKI OHSUGI, MOTOHIKO SUGI, KOJI TSUTA and HIDEFUMI KINOSHITA
    Anticancer Research September 2021, 41 (9) 4577-4586; DOI: https://doi.org/10.21873/anticanres.15271
  • You have access
    Ceruloplasmin Levels in Cancer Tissues and Urine Are Significant Biomarkers of Pathological Features and Outcome in Bladder Cancer
    YUTA MUKAE, HIDENORI ITO, YASUYOSHI MIYATA, KYOHEI ARAKI, TSUYOSHI MATSUDA, NOZOMI AIBARA, YUICHIRO NAKAMURA, TOMOHIRO MATSUO, HIDEKI SAKAI and KANAME OHYAMA
    Anticancer Research August 2021, 41 (8) 3815-3823; DOI: https://doi.org/10.21873/anticanres.15174
  • You have access
    The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer
    CHANG LIM HYUN, SUNG JOON PARK, HYE SUNG KIM, HYUN JOO SONG, HEUNG UP KIM, CHEOL LEE, DONG HUI LEE, YOUNG HEE MAENG, YOUNG SIL KIM and BOGUN JANG
    Anticancer Research July 2021, 41 (7) 3689-3698; DOI: https://doi.org/10.21873/anticanres.15160

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 20
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire